ICAP

HPTN 067: Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (The ADAPT Study)

The ADAPT Study recruited men who have sex with men (MSM) and transgender women and was designed to identify oral pre-exposure prophylaxis (PrEP) pill-taking schedules that participants are more likely to follow and determine if these schedules influence healthier sexual practices.


Report Links:

Mannheimer, et. al. 2019. https://pubmed.ncbi.nlm.nih.gov/30865051/ Factors associated with sex-related pre-exposure prophylaxis adherence among men who have sex with men (MSM) in New York City in HPTN 067 . JAIDS.

Franks, et. al. https://link.springer.com/article/10.1007%2Fs10461-017-1964-6 Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study . AIDS and Behavior.

Web Links:

https://clinicaltrials.gov/ct2/show/NCT01327651

Status

Past

Locations

Our Approach

Research

Health Challenges

HIV/AIDS

Funders

NIH